← Back to Search

Health Improvement Program for Lupus

N/A

Waitlist Available

Led By Paul R Fortin, MD,FRCP,MPH

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

SLE according to ACR Criteria

Age over 18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is for a program to improve the health of people with Lupus, it includes 4 knowledge sessions, telephone follow-ups, and counseling.

Who is the study for?

This trial is for women over 18 with systemic lupus erythematosus (SLE) who can read and write in English or French. It's not suitable for those with osteoporosis-related fractures, peripheral vascular disease, current pregnancy or plans within a year, cancer, stroke, other arterial blockages, angina or history of heart attack.Check my eligibility

What is being tested?

The HIPP program aims to improve overall health in SLE patients by reducing heart attack and bone loss risks through personalized care plans. This includes educational sessions on lupus management and lifestyle changes supported by nurse case managers compared to usual care.See study design

What are the potential side effects?

Since the intervention focuses on education and lifestyle modification rather than medication, typical drug side effects are not expected. However, participants may experience stress related to lifestyle adjustments or from learning about their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with lupus.

Select...

I am over 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Coordinated intervention will improve health status of patients with Lupus compared with usual care

Intervention will significantly decrease the number of cardiovascular risk factors and will improve flow mediated dilatation ( a non invasive measure of edothelial health

Secondary outcome measures

Improve bone health behaviours and prevent decrease in bone mineral density

cost effective intervention that could become standard of care in lupus

help persons with lupus move toward on the illness-wellness continuum by increasing their knowledge of Lupus

+1 more

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,466 Previous Clinical Trials

483,996 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,339 Previous Clinical Trials

25,752,338 Total Patients Enrolled

The Arthritis Society, CanadaOTHER

24 Previous Clinical Trials

5,262 Total Patients Enrolled

Media Library

Health Improvement and Prevention Program (HIPP) Clinical Trial Eligibility Overview. Trial Name: NCT00188357 — N/A

Lupus Clinical Trial 2023: Health Improvement and Prevention Program (HIPP) Highlights & Side Effects. Trial Name: NCT00188357 — N/A

Health Improvement and Prevention Program (HIPP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00188357 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available for this trial?

"The clinical trial registry on clinicialtrials.gov confirms that this medical study is no longer recruiting patients, having been initially posted in August 2003 and last updated February 2007. However, 125 other trials are still actively seeking participants at the time of writing."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus

2003. "HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00188357.

All > Health > Lupus